Preclinical systematic reviews hold untapped potential to inform science and policy, but too often, they’re produced in isolation, with unclear relevance for decision-makers. How can we change that?
This project tackles this major gap by asking three simple but powerful questions:
- Who are the interest holders for preclinical systematic reviews?
- What information do they need from preclinical studies?
- How can we meaningfully engage them in the systematic review process?
We invite you to join our team as we collaboratively develop a white paper to answer these questions and offer practical guidance to make preclinical systematic reviews more relevant, inclusive, and actionable. Whether you’re a researcher, regulator, funder, or patient partner, your voice matters. Let’s build a stronger bridge between preclinical science and real-world decisions, together.
